Xinchang, China

Wei Wei

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Wei Wei

Introduction

Wei Wei is an accomplished inventor based in Xinchang County, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. His innovative work has garnered attention for its potential impact on healthcare.

Latest Patents

Wei Wei holds a patent for a glycopeptide compound or pharmaceutical salt thereof, along with a method for preparing the same and pharmaceutical compositions and applications thereof. This invention provides a glycopeptide compound that exhibits in-vitro antibacterial activity, which is crucial for the development of new antibacterial agents. The details of the compound are outlined in the patent, where the definitions of R, R, R, R, and R are specified.

Career Highlights

Throughout his career, Wei Wei has focused on advancing pharmaceutical research and development. His work has led to the creation of innovative compounds that address pressing health concerns. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.

Collaborations

Wei Wei has collaborated with notable colleagues, including Dingfeng Zhang and Yuanyuan Ge. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Wei Wei's contributions to the field of pharmaceuticals, particularly through his patented glycopeptide compound, highlight his role as an innovative inventor. His work not only advances scientific knowledge but also holds promise for improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…